Skip to content

Body fluid-based multi-omics gastric cancer marker screening, predictive modeling, and pathogenesis research

Body fluid-based multi-omics gastric cancer marker screening, predictive modeling, and pathogenesis research

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500107890
Enrollment
Unknown
Registered
2025-08-20
Start date
2025-08-20
Completion date
Unknown
Last updated
2025-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

Superficial gastritis observation group:None
Precancerous lesion observation group:None

Sponsors

Wuxi People's Hospital Affiliated to Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Patient is older than 18 years and not older than 75 years, regardless of gender; 2.Patient agrees and is able to sign an informed consent form; 3.Patients with a definite pathological diagnosis of gastric malignancy or gastric precancerous lesions;

Exclusion criteria

Exclusion criteria: 1.Patients with co-morbid autoimmune diseases or other malignant tumors; 2.Any other factor that the investigator believes the patient is potentially at risk or that interferes with the patient's;

Design outcomes

Primary

MeasureTime frame
Gastric cancer or gastric precancerous lesions;

Secondary

MeasureTime frame
Environmental risk factors of gastric cancer or gastric precancerous lesions;Multi-omics analysis of biomarker risk scores of gastric cancer or gastric precancerous lesions;

Countries

China

Contacts

Public ContactAn Fangmei

Wuxi People's Hospital Affiliated to Nanjing Medical University

wdf8025@163.com+86 510 8535 0123

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026